|
Volumn 17, Issue 2, 2004, Pages 143-146
|
NASPAG/JPAG roundtable discussion annual clinical meeting 2003-Philadelphia, PA: Sexually Transmitted Diseases (STD) treatment guidelines 2002
a b c d |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZITHROMYCIN;
CEFPODOXIME;
CEFTRIAXONE;
CEPHALOSPORIN;
CYCLOSPORIN;
DOXYCYCLINE;
NONOXINOL 9;
SPECTINOMYCIN;
VALACICLOVIR;
ADOLESCENT;
ARTICLE;
CHLAMYDIA;
CHLAMYDIASIS;
CLINICAL TRIAL;
CONDOM;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
GASTROINTESTINAL TOXICITY;
GENITAL ULCER;
GONORRHEA;
HERPES;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PREGNANCY;
PREVALENCE;
PRIORITY JOURNAL;
SEXUAL BEHAVIOR;
SEXUALLY TRANSMITTED DISEASE;
SIDE EFFECT;
UNITED STATES;
URETHRITIS;
UTERINE CERVICITIS;
HUMANS;
PRACTICE GUIDELINES;
SEXUALLY TRANSMITTED DISEASES;
|
EID: 1642487793
PISSN: 10833188
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpag.2004.01.009 Document Type: Article |
Times cited : (2)
|
References (4)
|